{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:30:35Z","timestamp":1786480235654,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2025,5]]},"abstract":"\n Key Points<\/jats:title>\n \n \n \n Modifying genes may alter the phenotype of patients with Alport syndrome.<\/jats:p>\n <\/jats:list-item>\n \n There is intrafamilial and interfamilial phenotype variation in Alport syndrome.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n \n Alport syndrome (AS) is an inherited disorder characterized by progressive kidney disease, hearing deficits, and ocular abnormalities. This study investigates phenotypic variability among individuals with identical autosomal genetic mutations in\n COL4A3<\/jats:italic>\n and explores the potential influence of modifier genes. The study focuses on three families carrying the same\n COL4A3<\/jats:italic>\n mutation (\n c.2083G>A<\/jats:italic>\n ,\n p.Gly695Arg<\/jats:italic>\n ), but exhibiting differences in phenotype. The objective was to elucidate interfamilial and intrafamilial variations and identify potential genetic modifiers contributing to these differences.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Three families from a cohort at the University of Utah were studied. Clinical data, blood, urine, and tissue samples were collected with informed consent. Whole-exome sequencing was performed to identify genetic variants, using the SureSelect Human All Exon Target Enrichment System. Variant calling and annotation were conducted with Genome Analysis Tool Kit, variant effect predictor, and PEDDY. Disease\u2013gene prioritization was achieved using the Variant Annotation, Analysis, and Search Tool; Pedigree Variant Annotation, Analysis, and Search Tool; and the Phenotype Driven Variant Ontological Reranking Tool. Modifier genes were identified through cosegregation analysis and functional annotation using public databases.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The study highlighted significant phenotypic variability within and between families with the same\n COL4A3<\/jats:italic>\n mutation. Individuals with single mutations often presented mild phenotypes, such as isolated hematuria, whereas compound heterozygotes and digenic cases exhibited severe manifestations, including proteinuria, hearing loss, and CKD. Modifier genes such as GRIP1, CCND1, and CYP3A7 were identified and linked to phenotypic variability, suggesting their potential role in disease progression.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The findings underscore the role of genetic modifiers in influencing phenotypic variability in AS. Understanding these modifiers is crucial for personalized therapeutic strategies and genetic counseling. Future research should validate these candidate genes through functional studies and larger cohorts to enhance clinical care and improve prognostic predictions for patients with AS.<\/jats:p>\n <\/jats:sec>","DOI":"10.34067\/kid.0000000722","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T12:03:13Z","timestamp":1739534593000},"page":"824-834","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Renal Phenotype Variations among Families with Autosomal Alport Syndrome"],"prefix":"10.34067","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2661-4882","authenticated-orcid":false,"given":"Abdelrahman","family":"Ibrahim","sequence":"first","affiliation":[{"name":"Nephrology Division, Internal Medicine Department, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Lin","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mack","family":"Hinckley","sequence":"additional","affiliation":[{"name":"Nephrology Division, Internal Medicine Department, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazdak","family":"Khalighi","sequence":"additional","affiliation":[{"name":"Dermatology Department, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zena","family":"Altawallbeh","sequence":"additional","affiliation":[{"name":"Nephrology Division, Internal Medicine Department, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5146-9544","authenticated-orcid":false,"given":"Daher","family":"Al-Rabadi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakariya","family":"Al-Hassanat","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus G.","family":"Pezzolesi","sequence":"additional","affiliation":[{"name":"Nephrology Division, Internal Medicine Department, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7323-7653","authenticated-orcid":false,"given":"Martin C.","family":"Gregory","sequence":"additional","affiliation":[{"name":"Nephrology Division, Internal Medicine Department, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-9721","authenticated-orcid":false,"given":"Laith","family":"Al-Rabadi","sequence":"additional","affiliation":[{"name":"Nephrology Division, Internal Medicine Department, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"14","key":"B1-20250530","first-page":"1566","article-title":"[Hereditary kidney diseases in adults]","volume":"47","author":"Gr\u00fcnfeld","year":"1997","journal-title":"Rev Prat."},{"issue":"3","key":"B2-20250530","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J Am Soc Nephrol."},{"issue":"9","key":"B3-20250530","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.ekir.2022.06.001","article-title":"Heterozygous pathogenic COL4A3 and COL4A4 variants (autosomal dominant alport syndrome) are common, and not typically associated with end-stage kidney failure, hearing loss, or ocular abnormalities","volume":"7","author":"Savige","year":"2022","journal-title":"Kidney Int Rep."},{"issue":"9","key":"B4-20250530","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence estimates of predicted pathogenic COL4A3\u2013COL4A5 variants in a population sequencing database and their implications for alport syndrome","volume":"32","author":"Gibson","year":"2021","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B5-20250530","doi-asserted-by":"crossref","first-page":"100631","DOI":"10.1016\/j.xkme.2023.100631","article-title":"Alport syndrome: clinical spectrum and therapeutic advances","volume":"5","author":"Gregorio","year":"2023","journal-title":"Kidney Med."},{"issue":"7","key":"B6-20250530","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2215\/CJN.19171220","article-title":"Genetic basis of type IV collagen disorders of the kidney","volume":"16","author":"Quinlan","year":"2021","journal-title":"Clin J Am Soc Nephrol."},{"issue":"11","key":"B7-20250530","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1681\/ASN.2007040444","article-title":"COL4A3\/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy","volume":"18","author":"Voskarides","year":"2007","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B8-20250530","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/cge.13150","article-title":"Digenic inheritance and genetic modifiers","volume":"93","author":"Deltas","year":"2018","journal-title":"Clin Genet."},{"issue":"10","key":"B9-20250530","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.ekir.2023.07.010","article-title":"The phenotypic spectrum of COL4A3 heterozygotes","volume":"8","author":"Solanki","year":"2023","journal-title":"Kidney Int Rep."},{"issue":"4","key":"B10-20250530","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ajhg.2014.03.010","article-title":"PHEVOR combines multiple biomedical ontologies for accurate identification of disease-causing alleles in single individuals and small nuclear families","volume":"94","author":"Singleton","year":"2014","journal-title":"Am J Hum Genet."},{"issue":"1","key":"B11-20250530","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1750-1172-7-100","article-title":"Challenge in pathologic diagnosis of Alport syndrome: evidence from correction of previous misdiagnosis","volume":"7","author":"Yao","year":"2012","journal-title":"Orphanet J Rare Dis."},{"issue":"3","key":"B12-20250530","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1681\/ASN.2017090997","article-title":"Pathogenicity of a human laminin \u03b22 mutation revealed in models of alport syndrome","volume":"29","author":"Funk","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B13-20250530","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1681\/ASN.2014111109","article-title":"Podocyte p53 limits the severity of experimental alport syndrome","volume":"27","author":"Fukuda","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B14-20250530","doi-asserted-by":"crossref","first-page":"BSR20203248","DOI":"10.1042\/BSR20203248","article-title":"NPHS2 gene polymorphism aggravates renal damage caused by focal segmental glomerulosclerosis with COL4A3 mutation","volume":"41","author":"Sun","year":"2021","journal-title":"Biosci Rep."},{"issue":"1","key":"B15-20250530","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ng.505","article-title":"Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis","volume":"42","author":"Brown","year":"2010","journal-title":"Nat Genet."},{"issue":"2","key":"B16-20250530","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ng1292","article-title":"A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1","volume":"36","author":"Takamiya","year":"2004","journal-title":"Nat Genet."},{"issue":"1","key":"B17-20250530","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13000-019-0790-8","article-title":"Expression of cyclin D1 in clear cell sarcoma of kidney. Is it useful in differentiating it from its histological mimics?","volume":"14","author":"Uddin","year":"2019","journal-title":"Diagn Pathol."},{"issue":"1","key":"B18-20250530","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1523-1755.2000.00149.x","article-title":"Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies","volume":"58","author":"Barisoni","year":"2000","journal-title":"Kidney Int."},{"key":"B19-20250530","doi-asserted-by":"crossref","first-page":"714320","DOI":"10.3389\/fcell.2021.714320","article-title":"Cell cycle dysregulation and renal fibrosis","volume":"9","author":"Wu","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"1","key":"B20-20250530","doi-asserted-by":"crossref","first-page":"18064","DOI":"10.1038\/s41598-018-36085-w","article-title":"Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patients","volume":"8","author":"Sohn","year":"2018","journal-title":"Sci Rep."},{"issue":"1","key":"B21-20250530","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/156652413804486250","article-title":"Podocyte mitosis \u2013 a catastrophe","volume":"13","author":"Lasagni","year":"2013","journal-title":"Curr Mol Med."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:59:15Z","timestamp":1786478355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000722"}},"subtitle":["Potential Role of Modifier Genes"],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000722","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"2024-09-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}